|
1）Ito E, Toki T. The molecular mechanism of leukemogenesis in Down syndrome-related acute megakaryocytic leukemia. Nihon Rinsho. 2007; 65: 136-40
|
|
|
|
2）Yoshida K, Toki T, Okuno Y, et al. The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet. 2013; 45: 1293-9
|
|
|
|
|
3）Manabe A. Molecular mechanism and treatment of juvenile myelomonocytic leukemia (JMML). Rinsho Ketsueki. 2012; 53: 729-33
|
|
|
|
|
4）Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol. 2011; 152: 677-87
|
|
|
|
|
|
5）Matsuda K, Shimada A, Yoshida N, et al. Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations. Blood. 2007; 109: 5477-80
|
|
|
|
|
|
6）Doisaki S, Muramatsu H, Shimada A, et al. Somatic mosaicism for oncogenic NRAS mutations in juvenile myelomonocytic leukemia. Blood. 2012; 120: 1485-8
|
|
|
|
|
|
7）Sakaguchi H, Okuno Y, Muramatsu H, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013; 45: 937-41
|
|
|
|
|
|
8）Ismael O, Shimada A, Hama A, et al. Mutations profile of polycythemia vera and essential thrombocythemia among Japanese children. Pediatr Blood Cancer. 2012; 59: 530-5
|
|
|
|
|
|
9）Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013; 369: 2379-90
|
|
|
|
|
|
10）Teofili L, Foà R, Giona F, et al. Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients? Haematologica. 2008; 93: 169-72
|
|
|
|
|
|
11）Klion AD. Eosinophilic myeloproliferative disorders. Hematology Am Soc Hematol Educ Program. 2011; 2011: 257-63
|
|
|
|
|
|
12）Torrelo A, Alvarez-Twose I, Escribano L. Childhood mastocytosis. Curr Opin Pediatr. 2012; 24: 480-6
|
|
|
|
|
|
13）Yabe M, Masukawa A, Kato S, et al. Systemic mastocytosis associated with t(8; 21) acute myeloid leukemia in a child: detection of the D816A mutation of KIT. Pediatr Blood Cancer. 2012; 59: 1313-6
|
|
|
|
|
|
14）Ismael O, Shimada A, Hama A, et al. De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics. Br J Haematol. 2012; 158: 129-37
|
|
|
|
|